| Document |
Document Title |
|
WO/2024/031002A1 |
This disclosure includes pesticidal compounds, compositions, and related agricultural methods.
|
|
WO/2024/002889A1 |
The invention relates to compounds of formula (I) : as well as stereoisomeric forms, mixtures of stereoisomeric forms, and salts thereof, wherein R1, R2, R3, R4 and R5 are as defined in claim 1. Compounds of formula (I) are particularly ...
|
|
WO/2023/240047A1 |
A porous framework in the form of a crystalline powder for gradual release of an active guest compound, such as volatile guests. The porous framework comprises a 3-dimensional host matrix of interconnected pores and open channels configu...
|
|
WO/2023/160509A1 |
Provided in the present invention are an amidine derivative compound as represented by formula I, and a preparation method therefor and the use thereof. The amidine derivative compound of the present invention has Nav1.8 selective inhibi...
|
|
WO/2023/077235A1 |
The present invention discloses novel pentamidine analogues such as pentamidine analogs having the general formula: (1a) wherein: X is C, N, or –CH-CH-, Y is Y1 when X is N, and Y is Y1 and Y2 when X is C, or –CH-CH-, Y1, or Y1 and Y...
|
|
WO/2023/051261A1 |
The present invention belongs to the field of insecticides and acaricides, and specifically relates to an imine compound and the use thereof. The structure is as represented by general formula I, wherein each substituent in the formula i...
|
|
WO/2023/047285A1 |
The present invention relates to a novel process for preparing phenylamidine compounds of formula (I) or of salts thereof (I) wherein, R1, R2, R3, R4, R5, R6, m, and R7 are as defined in the detailed description.
|
|
WO/2022/196491A1 |
The present invention provides a tin compound which is represented by general formula (1). (In formula (1), each of R1 and R2 independently represents an alkyl group having 1 to 5 carbon atoms or an alkylsilyl group having 3 to 12 carbon...
|
|
WO/2022/120136A1 |
Provided herein, in part, are compounds and compositions useful for preparing pralsetinib. Also provided herein are processes for preparing pralsetinib.
|
|
WO/2022/108530A1 |
There is provided a perovskite precursor having the formula: Ia-Ib, wherein la is of the formula ABX3 or AB2X5, wherein A is one or more alkaline metals, B is lead and X is one or more halides; wherein lb is of the formula CBY3, wherein ...
|
|
WO/2022/087636A1 |
The present disclosure provides a group of amidine analogs and their pharmaceutically acceptable salts that are useful for treating a bacterial or fungal infection. The infection may include those infections caused by gram negative bacte...
|
|
WO/2022/024804A1 |
A compound having a perovskite crystal structure having A, B, and X as constituent components thereof (in the perovskite crystal structure, A is a monovalent positive ion and a component positioned at each vertex of a hexahedron centered...
|
|
WO/2021/250480A1 |
The present disclosure relates to a system for a composition for protein denaturation. The composition includes a non-nucleophilic denaturant comprising a substituted guanidine, wherein the denaturant has a pKa value greater than about 1...
|
|
WO/2021/127452A1 |
Compounds and methods for use to treat a bacterial infection caused by, for example, gram positive bacteria, gram negative bacteria, and/or mycobacteria are provided herein. Also provided herein are compounds and methods for use in poten...
|
|
WO/2021/007190A1 |
A process for preparing and purifying a compound of Formula (I) is provided; or a salt thereof, wherein the subscript m is an integer of from 0 to 3; each Ra is independently selected from the group consisting of (C3-C8)cycloalkyl, (C1-C...
|
|
WO/2020/252536A1 |
A method for producing a crystalline hydrogen-bonded organic framework (HOF) that encapsulates a bio-molecule, the method comprising combining in a solution the bio-molecule and a HOF precursor, wherein the HOF precursor self-assembles t...
|
|
WO/2020/237378A1 |
The present disclosure relates to compounds of the formula (I) which are precursor compounds of esters, whereby upon hydrolysis of the precursor compound, an ester compound is released. This ester precursor approach can be useful for app...
|
|
WO/2020/237131A1 |
This disclosure relates to aryl amidines of Formula I and their use as fungicides. One embodiment of the present disclosure is a use of a compound of Formula I, for protection of a plant against attack by a phytopathogenic organism or th...
|
|
WO/2020/215895A1 |
The present invention relates to the technical field of medicine, and relates to derivatives represented by formula 1 and formula 2 in which a carboxylic acid group is introduced into the structure of ginkgolide B by means of a hydroxyl ...
|
|
WO/2020/202131A1 |
A method for obtaining a salt with a general formula: RxNI, wherein: RxN is an organic cation (RxN+), R represents substituents (R-) independently selected from a group consisting of organic substituents: R1-, R2-, R3- and hydrogen (H-),...
|
|
WO/2020/132636A1 |
The present disclosure provides a group of aromatic (e.g., pyridinyl, pyrimidinyl, pyrazinyl, or phenyl) diamidine analogs and pharmaceutically acceptable salts that are useful for treating a proliferative disease. The proliferative dise...
|
|
WO/2020/081829A1 |
Compounds, compositions, and methods for the treatment of infections caused by Acanthamoeba or Balamuthia mandnllaris trophozoites and/or cysts and for the disinfection of solids and/or liquids, such as medical and personal care items, f...
|
|
WO/2020/045326A1 |
The present invention provides a benzoic ester compound having an enteropeptidase inhibitory activity and a use of the compound as a medicine for the treatment or prevention of obesity, diabetes, etc. The compound is represented by formu...
|
|
WO/2020/035825A1 |
The present invention disclosed novel phenylamidine compounds of formula (I), wherein, Cy, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and m have the same meanings as defined in the description.The present invention further discloses a proce...
|
|
WO/2020/025501A1 |
The present invention relates to the field of chemical components for electrolyte compositions which are useful in electrochemical cells, such as lithium-ion batteries. More specifically, the invention provides new components and their c...
|
|
WO/2019/241566A1 |
Compounds and methods for the treatment of a bacterial infection or the potentiation of an antibiotic in treating a bacterial infection are described herein.
|
|
WO/2019/233250A1 |
Disclosed is a synthesis process for N-(ethoxycarbonylphenyl)-N'-methyl-N' phenylamidine, comprising specific steps of: simultaneously adding three raw materials, i.e. ethyl p-aminobenzoate, trialkyl orthoformate and N-methylaniline, syn...
|
|
WO/2019/232643A1 |
Perovskites have high density of vacancies which absorb oxygen molecules and upon illumination, transform them into superoxide species which react with perovskites to decompose them, preventing use of these materials in many photo-applic...
|
|
WO/2019/190354A1 |
The invention relates to organic chemistry, pharmacology, medicine and veterinary science and concerns the prophylaxis and treatment of infectious diseases caused by mycobacterial infections, in particular tuberculosis, with the aid of a...
|
|
WO/2019/161705A1 |
Disclosed is a new method for synthesizing 1,6-(p-amidinophenyl)hexyl diether, comprising the steps of: (1) preparing 1,6-(p-cyanophenyl)hexyl diether by reacting p-cyanophenol with 1,6-dibromohexane; (2) reacting the 1,6-(p-cyanophenyl)...
|
|
WO/2019/141740A1 |
The present invention related to compounds of Formula (I): or an agronomically acceptable salt thereof, wherein Q, X, Z, R2 and R3 are as described herein. The inventions further relates to compositions comprising said compounds, to meth...
|
|
WO/2019/095046A1 |
Compounds useful in inhibiting endo-exonuclease activity and treating cancer have the formula (I) wherein R3 is selected from the group consisting of loweralkyl, oxyalkyl, cycloalkyl, aryl, heteroaryl, heterocycloalkyl, aminoalkyl or a h...
|
|
WO/2019/092721A1 |
Complexes comprising a coordinated Cu(II) ion are described herein, which are capable of binding to an extracellular portion of Ctr1 such that the complex with the Cu(II) ion is transported through the Ctr1. The complexes may comprise a ...
|
|
WO/2019/088235A1 |
This organic-inorganic perovskite, which satisfies ET1
|
|
WO/2019/067113A1 |
Described herein is an hydrofluorocarboximidate of formula (I) where: RH is a linear or branched alkyl group comprising 1 or 2 carbon atoms and (a) Rf1 and Rf2 are independently selected from a linear or branched perfluorinated alkyl gro...
|
|
WO/2018/212356A1 |
Stable perovskite films having substantially-no phase transition within a predetermined temperature range are disclosed. In the films, formation of carrier traps is suppressed. Thermally stable perovskite solar cells and light-emitting d...
|
|
WO/2018/193385A1 |
The present invention relates to 4-substituted phenylamidine derivatives of the general formula (I), wherein R5-R6, ArA4, D, G, B, Q and an integer m have the meanings as defined in the description. The invention further relates to metho...
|
|
WO/2018/112649A1 |
The present application relates to amidine substituted analogues as shown in formula I and uses thereof as an anti-inflammatory agent and/or for the treatment of an immunological disorder or of an inflammatory bowel disease including ulc...
|
|
WO/2018/108998A1 |
The present invention relates to compounds of the formula (I), in particular to phenylamidines of the formula (I), to a process for their preparation, to the use of phenylamidines of the formula (I) according to the invention for control...
|
|
WO/2018/108992A2 |
The present invention relates to compounds of the formula (I), in particular to phenoxyphenylamidines of the formula (I), to a process for their preparation, to the use of phenoxyphenylamidines of the formula (I) according to the inventi...
|
|
WO/2018/102262A1 |
The invention provides novel inhibitors or inactivators of protein arginine deiminases, pharmaceutical compositions and methods of use thereof. The invention also relates to molecular probes based on such compounds and methods of use the...
|
|
WO/2018/091430A1 |
Compounds of the formula (I), wherein R1, R2, R3, R4 and R5 are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions,...
|
|
WO/2018/088079A1 |
Provided is a starting material for thin film formation which comprises a compound represented by general formula (1). (In the formula, R1 denotes a straight- or branched-chain alkyl group having 1-5 carbon atoms, R2 denotes a hydrogen a...
|
|
WO/2018/069833A1 |
The present invention relates to stable amorphous form of sacubitril valsartan trisodium complex and its solid dispersion compounds, processes for their preparation and pharmaceutical composition comprising the same. The present inventio...
|
|
WO/2018/069842A1 |
This invention relates to 4-substituted phenylamine derivatives of the general formula (I), wherein R1 to R8 and A have the meanings as defined in description. The invention further relates to methods for their preparation and use of sai...
|
|
WO/2018/069841A1 |
This invention relates to 4-substituted phenylamine derivatives of the general formula (I), wherein R1 to R9 and A have the meanings as defined in description. The invention further relates to methods for their preparation and use of sai...
|
|
WO/2017/222468A1 |
A carbon dioxide (CO2) sensitive dielectric nanocomposite, a capacitive CO2 sensor and a method for fabrication of the capacitive CO2 sensor are provided. The CO2 sensitive dielectric nanocomposite includes a low molecular weight organic...
|
|
WO/2017/155092A1 |
The present invention provides a composition for controlling a plant disease comprising a tetrazolinone compound represented by formula (1) wherein X1 represents a halogen atom etc., and X2 represents a C1-C3 alkyl group etc., and at lea...
|
|
WO/2017/105449A1 |
Embodiments of the present disclosure describe methods of synthesis of amidines, amidine-metal complexes, thin metal films formed using amidine-metal complexes on semiconductor devices, and semiconductor devices and systems with thin met...
|
|
WO/2017/102635A1 |
Compounds of the formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and X are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these...
|
